The American Pharmacists Association Foundation has unveiled its new Patient Self-Management Solutions aimed at reducing overall cost of care by approximately $1,000 per person with diabetes per year, improving health outcomes and increasing patient satisfaction.
The focus on education at McKesson’s ideaShare 2015 didn’t stop when the exhibit hall opened Thursday evening. Friday and Saturday in San Diego saw a robust lineup of Continuing Education and Lunch & Learn sessions that aimed to keep independent pharmacy owners and pharmacists apprised of the latest developments in patient care and the current state of the business.
The $1.1 billion deal is expected to close in the first quarter of 2016 and will include Bayer’s Contour line of blood glucose monitors and test strips, as well as lancing devices like Microlet and Elite.
The American Pharmacists Association Foundation’s diabetes management solution, the Patient Self-Management Credential for Diabetes, was highlighted at the Healthcare Leadership Council’s wellness briefing.
DexCom received Food and Drug Administration approval for its Dexcom G4 Platinum Continuous Glucose Monitor System with Share. The Share receiver uses a wireless connection via Bluetooth Low Energy between the patient’s receiver and an app on the patient’s smartphone to relay glucose information to apps on the mobile devices of up to five designated recipients, or “followers.”
Afrezza, an inhaled insulin powder, is now available by prescription in U.S. retail pharmacies, Sanofi and MannKind Corp. announced. The drug is approved by the Food and Drug Administration to control high blood sugar in adults who have type 1 and type 2 diabetes.
In December, DSN hosted its 14th annual Diabetes Roundtable, this time expanding the discussion to include other chronic conditions and community pharmacy’s role in driving prevention and improved health outcomes for patients.
Miraculins on Tuesday announced that it will be commencing a pilot program with Lovell Drugs and Pear Healthcare Solutions that will see the placement of the first stand-alone, Scout DS diabetes screening kiosks in Lovell’s retail pharmacy locations in Ontario.